Inventia Healthcare Limited
FDA Approved Drugs

Inventia Healthcare Limited

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Unclassified
  • Total Records 17
  • Latest Approval Date Aug 19, 2019
  • Data Source FDA
  • First Approval Date Nov 20, 2017
All
17
View
Unclassified
9
View
RX
8
View
Company Overview

Company

Inventia Healthcare Limited

Country

India

Website

Visit Website

Email

business.enquiry@inventiahealthcare.com

Social Profiles

LinkedIn
Company Snapshot

Inventia Healthcare Limited

Unit 703 and 704, 7th Floor, Hubtown Solaris, N S Phadke Marg, Andheri (East), Mumbai, Maharashtra

India

www.inventiahealthcare.com/ business.enquiry@inventiahealthcare.com View on Map
FDA Approved Drug Records ( 17 records )
2018
03 May
RX Application: 209696

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2018-05-03

209696 / 1

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

209696

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2018-05-03

Regulatory Status

RX

2018
03 May
RX Application: 209696

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

7.5MG

Approval Date

2018-05-03

209696 / 2

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

209696

Product Number

2

Dosage Form

-

Strength

7.5MG

Approval Date

2018-05-03

Regulatory Status

RX

2018
03 May
RX Application: 209696

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2018-05-03

209696 / 3

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

209696

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2018-05-03

Regulatory Status

RX

2018
03 May
RX Application: 209696

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2018-05-03

209696 / 4

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

209696

Product Number

4

Dosage Form

-

Strength

15MG

Approval Date

2018-05-03

Regulatory Status

RX

2018
03 May
RX Application: 209696

Drug Name

BUSPIRONE HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2018-05-03

209696 / 5

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Application Number

209696

Product Number

5

Dosage Form

-

Strength

30MG

Approval Date

2018-05-03

Regulatory Status

RX

-
Unclassified Application: 219755

Drug Name

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

219755 / 2

Active Ingredient

DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

219755

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219755

Drug Name

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

-

219755 / 3

Active Ingredient

DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

219755

Product Number

3

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219755

Drug Name

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

500MG

Approval Date

-

219755 / 4

Active Ingredient

DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

219755

Product Number

4

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219755

Drug Name

DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

-

219755 / 5

Active Ingredient

DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE

Application Number

219755

Product Number

5

Dosage Form

-

Strength

2.5MG

Approval Date

-

Regulatory Status

Unclassified

2017
20 Nov
RX Application: 209695

Drug Name

FLUOXETINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2017-11-20

209695 / 1

Active Ingredient

FLUOXETINE HYDROCHLORIDE

Application Number

209695

Product Number

1

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

2017-11-20

Regulatory Status

RX

-
Unclassified Application: 215411

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

215411 / 2

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

215411

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 215411

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

215411 / 3

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

215411

Product Number

3

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217829

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

-

217829 / 2

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

217829

Product Number

2

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217829

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

217829 / 3

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

217829

Product Number

3

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 217829

Drug Name

SITAGLIPTIN AND METFORMIN HYDROCHLORIDE

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

217829 / 4

Active Ingredient

SITAGLIPTIN, METFORMIN HYDROCHLORIDE

Application Number

217829

Product Number

4

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

2019
19 Aug
RX Application: 204562

Drug Name

TOLTERODINE TARTRATE

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2019-08-19

204562 / 1

Active Ingredient

TOLTERODINE TARTRATE

Application Number

204562

Product Number

1

Dosage Form

-

Strength

2MG

Approval Date

2019-08-19

Regulatory Status

RX

2019
19 Aug
RX Application: 204562

Drug Name

TOLTERODINE TARTRATE

Product Number

2

Dosage Form

-

Strength

4MG

Approval Date

2019-08-19

204562 / 2

Active Ingredient

TOLTERODINE TARTRATE

Application Number

204562

Product Number

2

Dosage Form

-

Strength

4MG

Approval Date

2019-08-19

Regulatory Status

RX

Related Databases
  • FDA Inspections
    4 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    17 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
17 total
  • RX
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

BUSPIRONE HYDROCHLORIDE

Application Number

209696

Product Number

1

Active Ingredient

BUSPIRONE HYDROCHLORIDE

Dosage Form

-

Strength

5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit